Journal profile
Molecular Biology Nanomedicine
ISSN 2707-4692 · Techland Publishing Group Limited · Hong Kong
Molecular Biology Nanomedicine: diamond open access (no APC); no APC; review about 5 weeks (community reports).
Scope
Aims, scope and focus
Molecular Biology Nanomedicine is published by Techland Publishing Group Limited. By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, Autophagy in Disease and Therapy and Gastric Cancer Management and Outcomes, together about 23.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Molecular Biology & Nanomedicine (MBN) will publish all areas of molecular biology and nano-medicine, including basic research in nanobiology, technology transformation, industrialization demonstration, etc. This journal is aimed to provide a platform for communication, sharing, and discussion in the fields of biology and nanoscience for scientists, scholars, and researchers. The areas covered include (but are not restricted to): biomolecules/surfaces interactions studies self-assembly of biological molecules artificial cells regenerative medicine gene therapy/diagnostics infectious disease new drug R&D molecular probes targeted drugs nanotechnology nanobiotechnology nanomedicine stem cell and tissue engineering nanomedical devices biomimetics, and bioinformatics interactions of nanomaterials with cells, tissues
From the journal's Aims & Scope
Editorial board by country: 20 in mainland China (about 91%); most named Mainland China 20, United States 2 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology8.8%
- Autophagy in Disease and TherapyMedicine8.8%
- Gastric Cancer Management and OutcomesMedicine5.9%
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology5.9%
- Endoplasmic Reticulum Stress and DiseaseBiochemistry, Genetics and Molecular Biology5.9%
- Traditional Chinese Medicine StudiesMedicine5.9%
- Medical Research and TreatmentsMedicine5.9%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 1OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 18 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2022 | 0 | 0 | 1 |
| 2021 | 7 | 7 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 5 weeksLetPub ·
- Submission to publication (journal-reported)
- about 5 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- No page charges
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Templates
- Word
- Cover letter
- Required
Article types accepted9
- case reportThe main article types are as follows: Original Article Review Meta-Analysis Case Report Commentary Editorial Letter to Editor Communication The articles publis…Length not stated
- commentaryThe main article types are as follows: Original Article Review Meta-Analysis Case Report Commentary Editorial Letter to Editor Communication The articles publis…Length not stated
- communicationCommunicationLength not stated
- editorialThe main article types are as follows: Original Article Review Meta-Analysis Case Report Commentary Editorial Letter to Editor Communication The articles publis…Length not stated
- letterThe main article types are as follows: Original Article Review Meta-Analysis Case Report Commentary Editorial Letter to Editor Communication The articles publis…Length not stated
- letter to editorLetter to EditorLength not stated
- meta-analysisThe main article types are as follows: Original Article Review Meta-Analysis Case Report Commentary Editorial Letter to Editor Communication The articles publis…Length not stated
- original articleThe main article types are as follows: Original Article Review Meta-Analysis Case Report Commentary Editorial Letter to Editor Communication The articles publis…Length not stated
- reviewThe main article types are as follows: Original Article Review Meta-Analysis Case Report Commentary Editorial Letter to Editor Communication The articles publis…Length not stated
Policy excerpts from the journal's websitePublication ethics, Open access, Peer review, Plagiarism
- Publication ethics Publication Ethics Statement
The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high-quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of Cancer Molecular Biology & Nanomedicine take…
Source ↗Publisher website ·- Open access Open Access
Originality: submissions must be unpublished and not under consideration elsewhere. Model summary
All articles published by Molecular Biology & Nanomedicine will be Open-Access articles, are made freely and permanently accessible online immediately from the date of publication. Articles are published under a Creative Commons Attribution 4.0 International License. Authors retain the copyright of their works. Articles published in MBN will be Open-Access articles distributed under the terms and …
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Rigorous peer-review process with strict ethical policies. Model summary
The acceptance criteria for this Journal are based on the quality, originality and novelty of the researches, as well as the significance to readership. Except where otherwise stated, the Journal adheres to rigorous peer review process and undergoes single-blind peer review for all the manuscripts. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the qualit…
Source ↗Publisher website ·- Plagiarism
Zero tolerance for plagiarism; iThenticate similarity checking. Model summary
Plagiarism is not acceptable in this journal. Techland publishing has a partnership with iThenticate, which is the most trusted similarity checker. It is used to analyze received manuscripts to avoid plagiarism to the greatest extent possible.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Techland Publishing Group Limited
- Country or region
- Hong Kong
- Language
- English
- ISSN
- 2707-4692
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Molecular Biology Nanomedicine
How long does peer review take at Molecular Biology Nanomedicine?
Authors report an average review time of about 5 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Molecular Biology Nanomedicine?
According to the journal's author guidelines: Templates: Word; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Molecular Biology Nanomedicine based?
Of the 22 board members whose country the journal's board page names, 20 (about 91%) are in mainland China; the countries named most often are Mainland China (20) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Molecular Biology Nanomedicine?
According to LetPub and DOAJ records, Molecular Biology Nanomedicine is indexed in DOAJ.
Is Molecular Biology Nanomedicine open access, and what is the APC?
Molecular Biology Nanomedicine is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .